A Divergent Platelet Transcriptome in Patients with Lipedema and Lymphedema
Genes · 2024
DOI: 10.3390/genes15060737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Alliefair Scalise und 7 weiteren Autor:innen. Beteiligte Einrichtung: Heart Vascular and Thoracic Institute, Department of Cardiovascular Medicine, Section of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, O…. Hauptthemen laut MEDLINE: Lymphedema, Lipedema, Transcriptome, Blood Platelets. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lipedema Fundation, NHLBI NIH HHS, Lipedema Foundation.
Abstract (Originalsprache)
Lipedema and lymphedema are physically similar yet distinct diseases that are commonly misdiagnosed. We previously reported that lipedema and lymphedema are associated with increased risk for venous thromboembolism (VTE). The underlying etiology of the prothrombotic profile observed in lipedema and lymphedema is unclear, but may be related to alterations in platelets. Our objective was to analyze the platelet transcriptome to identify biological pathways that may provide insight into platelet activation and thrombosis. The platelet transcriptome was evaluated in patients with lymphedema and lipedema, then compared to control subjects with obesity. Patients with lipedema were found to have a divergent transcriptome from patients with lymphedema. The platelet transcriptome and impacted biological pathways in lipedema were surprisingly similar to weight-matched comparators, yet different when compared to overweight individuals with a lower body mass index (BMI). Differences in the platelet transcriptome for patients with lipedema and lymphedema were found in biological pathways required for protein synthesis and degradation, as well as metabolism. Key differences in the platelet transcriptome for patients with lipedema compared to BMI-matched subjects involved metabolism and glycosaminoglycan processing. These inherent differences in the platelet transcriptome warrant further investigation, and may contribute to the increased risk of thrombosis in patients with lipedema and lymphedema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Vascular and Thoracic Institute, Department of Cardiovascular Medicine, Section of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
- Lerner Research Institute, Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
- Holman Division of Endocrinology, New York University, New York, NY 10012, USA.
- Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA.
- Department of Hematology, Taussig Cancer Center, Cleveland, OH 44195, USA.
ORCID-Profile: Alliefair Scalise, Jose O Aleman, Scott J Cameron
Förderung
- Lipedema Fundation
- NHLBI NIH HHS
- Lipedema Foundation
- donation from Mr. David Bradley
Zitieren
APA
Scalise, A., Aggarwal, A., Sangwan, N., Hamer, A., Guntupalli, S., Park, H. E., Aleman, J. O., & Cameron, S. J. (2024). A Divergent Platelet Transcriptome in Patients with Lipedema and Lymphedema. Genes. https://doi.org/10.3390/genes15060737
Vancouver
Scalise A, Aggarwal A, Sangwan N, Hamer A, Guntupalli S, Park HE, et al. A Divergent Platelet Transcriptome in Patients with Lipedema and Lymphedema. Genes. 2024. doi:10.3390/genes15060737
BibTeX
@article{Scalise2024,
author = {Scalise, Alliefair and Aggarwal, Anu and Sangwan, Naseer and Hamer, Annelise and Guntupalli, Suman and Park, Huijun Edelyn and Aleman, Jose O and Cameron, Scott J},
title = {A Divergent Platelet Transcriptome in Patients with Lipedema and Lymphedema},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15060737}
}
EUVIMED